738 related articles for article (PubMed ID: 21481794)
1. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.
Chen J; Yao Y; Gong C; Yu F; Su S; Chen J; Liu B; Deng H; Wang F; Lin L; Yao H; Su F; Anderson KS; Liu Q; Ewen ME; Yao X; Song E
Cancer Cell; 2011 Apr; 19(4):541-55. PubMed ID: 21481794
[TBL] [Abstract][Full Text] [Related]
2. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
Lin Z; Li W; Zhang H; Wu W; Peng Y; Zeng Y; Wan Y; Wang J; Ouyang N
Tumour Biol; 2016 Mar; 37(3):3461-8. PubMed ID: 26449829
[TBL] [Abstract][Full Text] [Related]
3. Discovery of CCL18 antagonist blocking breast cancer metastasis.
Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
[TBL] [Abstract][Full Text] [Related]
4. Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
Li HY; Cui XY; Wu W; Yu FY; Yao HR; Liu Q; Song EW; Chen JQ
J Cell Biochem; 2014 Mar; 115(3):596-603. PubMed ID: 24142406
[TBL] [Abstract][Full Text] [Related]
5. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
[TBL] [Abstract][Full Text] [Related]
6. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P
Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176
[TBL] [Abstract][Full Text] [Related]
8. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
[TBL] [Abstract][Full Text] [Related]
9. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid.
Hong R; Shen MH; Xie XH; Ruan SM
Asian Pac J Cancer Prev; 2012; 13(5):1877-80. PubMed ID: 22901140
[TBL] [Abstract][Full Text] [Related]
11. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
12. CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype.
Zeng W; Xiong L; Wu W; Li S; Liu J; Yang L; Lao L; Huang P; Zhang M; Chen H; Miao N; Lin Z; Liu Z; Yang X; Wang J; Wang P; Song E; Yao Y; Nie Y; Chen J; Huang D
Oncogene; 2023 Jan; 42(3):224-237. PubMed ID: 36418470
[TBL] [Abstract][Full Text] [Related]
13. CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.
Li H; Zhang D; Yu J; Liu H; Chen Z; Zhong H; Wan Y
J Cell Physiol; 2018 Apr; 233(4):3207-3217. PubMed ID: 28834540
[TBL] [Abstract][Full Text] [Related]
14. CCL18 in the Progression of Cancer.
Korbecki J; Olbromski M; Dzięgiel P
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114763
[TBL] [Abstract][Full Text] [Related]
15. CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.
Qin Y; Wang J; Zhu G; Li G; Tan H; Chen C; Pi L; She L; Chen X; Wei M; Li Z; Liu Z; Huang D; Liu Y; Zhang X
J Cell Mol Med; 2019 Apr; 23(4):2689-2701. PubMed ID: 30768878
[TBL] [Abstract][Full Text] [Related]
16. Chemokine
Ding D; Zhang L; Liu X; Sun C; He J; Li J; Gao X; Guan F; Zhang L
J Interferon Cytokine Res; 2022 Jan; 42(1):19-28. PubMed ID: 35041514
[TBL] [Abstract][Full Text] [Related]
17. Acetylation of ACAP4 regulates CCL18-elicited breast cancer cell migration and invasion.
Song X; Liu W; Yuan X; Jiang J; Wang W; Mullen M; Zhao X; Zhang Y; Liu F; Du S; Rehman A; Tian R; Li J; Frost A; Song Z; Green HN; Henry C; Liu X; Ding X; Wang D; Yao X
J Mol Cell Biol; 2018 Dec; 10(6):559-572. PubMed ID: 30395269
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma.
Ye H; Zhou Q; Zheng S; Li G; Lin Q; Wei L; Fu Z; Zhang B; Liu Y; Li Z; Chen R
Cell Death Dis; 2018 May; 9(5):453. PubMed ID: 29670110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
